Bullboard Post History

by askretka

Order by:

T.ONC	City of Hope CF33 doses first patient https://www.clinicaltrialsarena.com/news/imugene-solid-tumour-trial/ --------... May 21, 2022
T.ONC	More Keytruda vs Opdivo competition Staying in the back seat to Keytruda, Bristol Myers reports another pivotal... May 16, 2022
T.ONC	Biotechs fall after Roche trial failure. https://www.google.com/amp/s/ca.finance.yahoo.com/amphtml/news/cancer-drug... May 11, 2022
T.ONC	RE:RE:06 May 2022 $8.50 Target Maintained Yes you highlighted the two most important parts of his report. Adlai Nortye... May 7, 2022
T.ONC	06 May 2022 $8.50 Target Maintained https://leedejonesgable.com/wp-content/uploads/ONC_2022_05_06.pdf -----------... May 6, 2022
T.ONC	Bloomberg and Burton webcast Have a listen if you get a chance. Matt throwing out the possibility of a 2nd... May 4, 2022
V.SMN	NICE RESULTS Sun Summit discovers strong gold-silver-zinc mineralization west of Buck Main... May 3, 2022
T.ONC	15 Top selling cancer drugs 90 Billion in 2022 https://www.google.com/url?sa=t&source=web&rct=j&url=https... April 30, 2022
T.ONC	RE:ONCY pelareorep + bispecific antibodies in pancreatic cancer Yes Bispecific antibodies hold great promise going forward. The researchers... April 28, 2022
T.ONC	Turning up the heat on cold tumors https://www.genengnews.com/news/turning-up-the-heat-on-cold-tumors/ ---------... April 27, 2022
T.ONC	NEW RESEARCH REPORT 14 April 2922 https://leedejonesgable.com/wp-content/uploads/ONC_2022_04_14.pdf Try this... April 21, 2022
T.ONC	New 14 April Research Report highlights CAR-T https://leedejonesgable.com/wp- content/uploads/ONC_2022_04_14.pdf ----------... April 21, 2022
T.ONC	RE:RE:RE:Gilead sees 33% revenues will come from oncology by 2030 WHO), cancer is a growing burden, and the number of new cancer cases is going... April 20, 2022
V.ISGI	RE:With all their recent contracts/signings Well I'm traveling right now and every plane I've been on there are... April 15, 2022
T.ONC	13 April Researchers load CAR-T cells with Oncolytic virus https://www.sciencedaily.com/releases/2022/04/220413141538.htm --------------... April 13, 2022
T.ONC	RE:RE:RE:RE:Pfizer and Merck KGaA win over NICE on Bavencio coverage Yes it's positive for Oncolytics and breast cancer. A quick search shows... April 8, 2022
T.ONC	RE:Pfizer and Merck KGaA win over NICE on Bavencio coverage Intresting that Trodelvy that Gilead paid 21 Billion for was targeting... April 8, 2022
T.ONC	RE:RE:FDA "Project FrontRunner" - to advance accelerated approvals I wonder if this is anyway related to " Project Moonshot" that... April 6, 2022
T.ONC	For Notable Re: Last CAR-T Virus post You did a good summary there. It is interesting indeed that it may favor a... April 5, 2022
T.ONC	CAR-T + Oncolytics Virus 02 Mar 2022 Highly technical article but interesting... April 3, 2022

Become a member today, It's free!

Bullboard Post History

by askretka

City of Hope CF33 doses first patient

More Keytruda vs Opdivo competition

Biotechs fall after Roche trial failure.

RE:RE:06 May 2022 $8.50 Target Maintained

06 May 2022 $8.50 Target Maintained

Bloomberg and Burton webcast

NICE RESULTS

15 Top selling cancer drugs 90 Billion in 2022

RE:ONCY pelareorep + bispecific antibodies in pancreatic cancer

Turning up the heat on cold tumors

NEW RESEARCH REPORT 14 April 2922

New 14 April Research Report highlights CAR-T

RE:RE:RE:Gilead sees 33% revenues will come from oncology by 2030

RE:With all their recent contracts/signings

13 April Researchers load CAR-T cells with Oncolytic virus

RE:RE:RE:RE:Pfizer and Merck KGaA win over NICE on Bavencio coverage

RE:Pfizer and Merck KGaA win over NICE on Bavencio coverage

RE:RE:FDA "Project FrontRunner" - to advance accelerated approvals

For Notable Re: Last CAR-T Virus post

CAR-T + Oncolytics Virus 02 Mar 2022

Featured Company

Calima Energy Ord Shs CLMEF

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by askretka

Featured Company